| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-21 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-15 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-12 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-12 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-10 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |